EcoDrugPlus

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSPKIG00000001647
Gene Symbol: LOC111838904
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSPKIG00000005932
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSPKIG00000018611
Gene Symbol: LOC111849289
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSPKIG00000012703
Gene Symbol: LOC111845521
4 Cross references
150 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSPKIG00000020123
Gene Symbol: PRKCD
4 Cross references
205 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSPKIG00000025236
Gene Symbol: LOC111840581
3 Cross references
205 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSPKIG00000021922
Gene Symbol: PRKCE
3 Cross references
342 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSPKIG00000018288
Gene Symbol: PRKCH
3 Cross references
18 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSPKIG00000020480
Gene Symbol: PRKCI
3 Cross references
85 Possible Orthologues:

Protein Kinase C Iota Type-Like

Ensembl ID : ENSPKIG00000017768
Gene Symbol: LOC111853452
4 Cross references
85 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSPKIG00000025524
Gene Symbol: PRKCQ
3 Cross references
202 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSPKIG00000004934
Gene Symbol: PRKCQ
1 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).